Press release
Biologics Contract Development Market Projected to Reach $13.22 Billion by 2030 | CAGR: 10.4%
Biologics Contract Development Market
Report Scope:
This comprehensive study provides an accurate overview of the worldwide biologics contract development industry. Comprehensive analyses of sales volume, price, revenue, market share, and important companies are included. The market is further divided into segments by source, product service, indication, and region in the study, which offers a comprehensive picture of the state of the market.
Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/biologics-contract-development-market/request-for-sample
Market Definition:
The pharmaceutical industry is experiencing an intense modification pushed by the growing intricacy of drug advancement and the requirement for elevated productivity and economics. Thus, there is an evolution in the escalating predominance of biologics contract development, a tactical alliance that is amending the way pharmaceutical firms propose their production and distribution provocations.
Drivers and Trends:
• Advancing nations such as India and China are prominent options for outsourcing clinical trials to extensive populations with assorted disease loads. Governments in these nations reinforce outsourcing to allure foreign funding.
• One of the critical factors in the evolution of biologics contract development is the growing acquisition of progressive technology for biological production. Further, there has been an upswing in pharma and biopharma businesses outsourcing their R&D endeavors for clinical trials.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/biologics-contract-development-market/request-for-discount-pricing
Top Companies:
Many large businesses are devoting much of their effort to new product releases, partnerships, and market expansion in order to compete effectively. Here are the top companies in the biologics contract development market:
• Abzena Ltd
• AGC Biologics
• Ajinomoto Bio-Pharma
• Avid Bioservices
• Inc; Bionova Scientific Inc
• BioXcellence (Boehringer Ingelheim Biopharmaceuticals GmbH)
• Curia Global
• Inc.
• Fujiifilm Diosynth Biotechnologies
• Genscript
• KBI Biopharma
• LakePharma
Biologics Contract Development Market Report Highlights
• The mammalian source segment became the dominant sector in 2021. This is due to the main benefit of using mammalian cells for protein expression and creating mammalian proteins with proper post-translational modifications that offer a native structure.
• Many businesses are choosing to manufacture recombinant proteins and monoclonal antibodies; the process development segment is expected to grow in forthcoming years. Major biologics manufacturers provide process development to the client's business needs, regulatory constraints, and project timelines.
• Due to the high need for cancer therapy, the oncology segment accounted for the greatest share, encouraging more company investments in R&D and outsourcing.
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/biologics-contract-development-market
Segmental Outlook
Biologics Contract Development, Source Outlook (Revenue - USD Billion, 2018 - 2030)
• Microbial
• Mammalian
• Others
Biologics Contract Development, Product Service Outlook (Revenue - USD Billion, 2018 - 2030)
• Cell Line Development
o Microbial
o Mammalian
o Others
• Process Development
o Upstream
Microbial
Mammalian
Others
o Downstream
Impurity, isolation, & identification
Physicochemical characterization
Pharmaceutical analysis
Others
o By Product
MABs
Recombinant proteins
Others
o Others
Biologics Contract Development, Indication Outlook (Revenue - USD Billion, 2018 - 2030)
• Oncology
• Immunological disorders
• Cardiovascular disorders
• Hematological disorders
• Others
Country-Wise Insights
According to regional research, North America dominated the market. The region's growth is aided by tactical associations and accession and escalated demand for detailed testing services. Also, Asia Pacific is anticipated to emerge as the fastest-growing region in the biologics contract development market.
• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
More Trending Latest Reports by Polaris Market Research:
Cosmetic Surgery Market
https://www.polarismarketresearch.com/industry-analysis/cosmetic-surgery-market
Medical Disposable Market
https://www.polarismarketresearch.com/industry-analysis/medical-disposable-market
Sleep Apnea Devices Market
https://www.polarismarketresearch.com/industry-analysis/sleep-apnea-devices-market
Dialysis Catheters Market
https://www.polarismarketresearch.com/industry-analysis/dialysis-catheters-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biologics Contract Development Market Projected to Reach $13.22 Billion by 2030 | CAGR: 10.4% here
News-ID: 3876697 • Views: …
More Releases from Polaris Market Research & Consulting
Paper Bags Market In-Depth Research Report with Forecast to 2034 | Coveri, Amcor …
Paper Bags Market
The size of the global paper bags market was estimated at USD 6.09 billion in 2024 and is expected to expand at a CAGR of 4.2%, growing from USD 6.33 billion in 2025 to USD 9.17 billion by 2034.
What Are Paper Bags?
A paper bag is a bag made of paper, commonly used for shopping, packaging, and storing items, and is often considered an eco-friendly alternative to plastic bags…
Wood Coatings Market to accrue significant proceeds by 2034
Wood Coatings Market
The wood coatings market was estimated to be worth USD 12.88 billion in 2024 and is expected to register a CAGR of 2.8%, growing from USD 13.21 billion in 2025 to USD 16.93 billion by 2034.
What Are Wood Coatings?
Wood coatings are protective finishes applied to wooden surfaces to enhance their appearance and durability. These coatings include paints, stains, varnishes, and sealers, available in various colors and finishes. Wood…
Internet of Things Analytics Market Valuation Could Reach USD 307.72 Billion by …
Internet of Things Analytics Market
The global Internet of Things analytics market size was valued at USD 33.91 billion in 2024. It is anticipated to generate an estimated revenue of USD 307.72 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust CAGR of 24.7% over the forecasted timeframe of 2025-2034.
Market Overview
The Internet of Things (IoT) represents a digital…
Dynamic Molecular Computing Market Projected to Hit USD 2,039.25 Million by 2034 …
Dynamic Molecular Computing Market
The 2024 valuation of the dynamic molecular computing market was USD 689.10 million. The market is predicted to expand at a CAGR of 11.5% over the forecast period, growing from USD 766.83 million in 2025 to USD 2,039.25 million in 2034.
What Is Dynamic Molecular Computing?
Dynamic molecular computing, or molecular dynamics (MD), is a computational technique that simulates the movement of atoms and molecules over time, allowing scientists…
More Releases for Biologics
Biopharmaceutical CMO Market 2020 Business Scenario – Lonza, Boehringer Ingelh …
The report provides a valuable source of insightful data for business strategists and competitive analysis of Biopharmaceutical CMO Market. It provides the Biopharmaceutical CMO industry overview with growth analysis and futuristic cost, revenue and many other aspects. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tire Biopharmaceutical CMO study provides comprehensive data which enhances the understanding, scope and application of this report.
the…
Extracellular Matrix Market Detailed Analysis 2020: Top Companies like Coloplast …
The global extracellular matrix market by raw material segments was led by porcine segment. In 2018, the porcine segment held a largest market share of 41.09% of the extracellular matrix market, by raw material. However, the bovine segment is expected to be the fastest growing segments of the market in 2027 owing to more beneficial properties to treat various conditions which is expected to become the major factor for the…
Biopharmaceutical CMO Market 2018-2023 :Lonza, Boehringer Ingelheium, Samsung Bi …
Global Biopharmaceutical CMO Industry - A Global Market Overview (2018-2023) (Avail A 10% Off)
The "Global Biopharmaceutical CMO Market Research Report 2018-2023" is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides…
Global Biopharmaceutical CMO Market Key Profiles - Wuxi Biologics, Boehringer In …
Global Biopharmaceutical CMO Market was valued at USD 13296.29 million in the year 2019. Escalating number of patients suffering from various diseases with growing investment in the healthcare industry by government in major economies and increasing awareness among consumers regarding impact of various viruses on health, has been anticipated to infuse growth in the market for Biopharmaceutical CMO during the forecasting period of 2020-2025.
Get Free Sample Copy of this Research…
Plant-based Biologics
Increasing demand for biologics for various chronic diseases and rising investment in R&D for the production of biologics is expected to contribute significantly to the growth of plant-based biologics market. According to Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development…
Global Biopharmaceutical CMO Market 2018-2023| Lonza, Boehringer Ingelheium, Sam …
Albany, NY, 10th September : Recent research and the current scenario as well as future market potential of "Global Biopharmaceutical CMO Market - Analysis By Region, By Country: Opportunities and Forecast (2018-2023) - By Region (North America, Europe, APAC), By Country (U.S, Denmark, Germany, Switzerland, Korea, Japan, China)" globally.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to…
